Trial Profile
Documentation of the Efficacy and Safety of RoActemra in the Treatment of Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 30 Mar 2016 New trial record